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Abstract
Background: Theiler’s virus infection induces chronic demyelinating disease in mice and has been investigated as
an infectious model for multiple sclerosis (MS). IL-1 plays an important role in the pathogenesis of both the
autoimmune disease model (EAE) and this viral model for MS. However, IL-1 is known to play an important
protective role against certain viral infections. Therefore, it is unclear whether IL-1-mediated signaling plays a
protective or pathogenic role in the development of TMEV-induced demyelinating disease.
Methods: Female C57BL/6 mice and B6.129S7-Il1r1tm1Imx/J mice (IL-1R KO) were infected with Theiler’s murine
encephalomyelitis virus (1 x 106 PFU). Differences in the development of demyelinating disease and changes in the
histopathology were compared. Viral persistence, cytokine production, and immune responses in the CNS of
infected mice were analyzed using quantitative PCR, ELISA, and flow cytometry.
Results: Administration of IL-1β, thereby rending resistant B6 mice susceptible to TMEV-induced demyelinating
disease, induced a high level of Th17 response. Interestingly, infection of TMEV into IL-1R-deficient resistant C57BL/6
(B6) mice also induced TMEV-induced demyelinating disease. High viral persistence was found in the late stage of
viral infection in IL-1R-deficient mice, although there were few differences in the initial anti-viral immune responses
and viral persistent levels between the WT B6 and IL-1R-deficiecent mice. The initial type I IFN responses and the
expression of PDL-1 and Tim-3 were higher in the CNS of TMEV-infected IL-1R-deficient mice, leading to
deficiencies in T cell function that permit viral persistence.
Conclusions: These results suggest that the presence of high IL-1 level exerts the pathogenic role by elevating
pathogenic Th17 responses, whereas the lack of IL-1 signals promotes viral persistence in the spinal cord due to
insufficient T cell activation by elevating the production of inhibitory cytokines and regulatory molecules. Therefore,
the balance of IL-1 signaling appears to be extremely important for the protection from TMEV-induced
demyelinating disease, and either too much or too little signaling promotes the development of disease.
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Introduction
Toll-like receptors (TLRs) and interleukin-1 receptors
(IL-1Rs) are involved in the production of various cyto-
kines that are associated with the innate immune re-
sponse against many different infectious agents. TLRs
and IL-1Rs share many structural similarities and utilize
common downstream adaptive molecules after activation
by their ligands. In general, these innate immune
responses induced by TLRs and IL-1Rs are known to
play a protective role against various microbes [1]. How-
ever, several recent studies have indicated that these sig-
nals may also play a pathogenic role in viral infections
[2-4]. In addition to TLRs, IL-1Rs are also considered to
be important innate receptors because IL-1β, in particu-
lar, is a prominent cytokine that appears in the early
stage of microbial infections [3]. The IL-1R family con-
tains six receptors, including IL-1RI, which recognizes
the principal inflammatory cytokine IL-1β and the less
inflammatory cytokine IL-1α [1,5]. IL-1β is generated
from the cleavage of pro-IL-1β by caspase-1 in inflam-
masomes after infections, and the downstream signaling
cascade of the IL-1β-IL-1R interaction leads to the in-
duction of various proinflammatory cytokines and the
activation of lymphocytes [6]. IL-1β-deficient mice show
broad host susceptibility to various infections [7,8].
Moreover, IL-1RI-deficient mice are susceptible to cer-
tain pathogens, including Listeria monocytogenes [1].
Therefore, these responses to IL-1β are apparently crit-
ical for protection from many types of viruses and
microbes. However, the level of IL-1β has also been
linked to many different inflammatory autoimmune dis-
eases, including diabetes, lupus, arthritis, and multiple
sclerosis (MS) [1,4].
Theiler’s murine encephalomyelitis virus (TMEV) is a
positive-stranded RNA virus in the Picornaviridae family
[9]. TMEV establishes a persistent CNS infection in sus-
ceptible mouse strains that results in the development of
chronic demyelinating disease, and the system has been
studied as a relevant viral model for human multiple
sclerosis [10-12]. Cells infected with TMEV produce vari-
ous proinflammatory cytokines, including type I IFNs,
IL-6 and IL-1β [13]. TLR3 and TLR2 are involved in the
production of these cytokines following infection with
TMEV [14,15]. In addition, melanoma differentiation-
associated gene 5 and dsRNA-activated protein kinase R
are known to contribute to the production of proinflam-
matory cytokines [14,16]. These pathways also induce ac-
tivation of caspase-1, leading to the generation of IL-1β
and IL-1α, which contribute to further cytokine produc-
tion, such as IL-6 promoting the development of patho-
genic Th17 cells. Because IL-1β signals are associated
with both host protection from viral infections and
pathogenesis of inflammatory immune-mediated dis-
eases, we here investigated the role of IL-1β-mediated
signals in the development of TMEV-induced demyelin-
ating disease.
We have previously reported that Th17 cells preferen-
tially develop in an IL-6-dependent manner after TMEV
infection, and that Th17 cells promote persistent viral
infection and induce the pathogenesis of chronic demye-
linating disease [17]. In addition, our earlier studies indi-
cated that administration of either lipopolysaccharide
(LPS) or IL-1β, thereby inducing high levels of IL-6 pro-
duction, into resistant C57BL/6 (B6) mice renders the
mice susceptible to the development of TMEV-induced
demyelinating disease [18]. These results suggest that
an excessive level of IL-1β is harmful to TMEV-
induced demyelinating disease by generating high levels
of pathogenic Th17 cells [19]. In this study, we con-
firmed the role of excessive IL-1β in the generation of a
high level of Th17 cells in resistant B6 mice, supporting
the pathogenic mechanisms of IL-1β. Furthermore, we
have also utilized IL-1R-deficient mice to investigate
the role of IL-1β-mediated signaling in the develop-
ment of TMEV-induced demyelinating disease. Our
results indicate that the lack of IL-1 signaling in resis-
tant B6 mice also induced TMEV-induced demyelinat-
ing disease. The initial deficiencies in T cell function,
including cytokine production and high viral persis-
tence in the late stage of viral infection, were found in
IL-1R-deficient mice. Therefore, the presence of an ex-
cessive amount of IL-1 plays a pathogenic role by ele-
vating pathogenic Th17 responses, whereas the lack of
IL-1 signals promotes viral persistence in the spinal




Female C57BL/6 mice were purchased from the Charles
River Laboratories (Charles River, MA, USA) through
the National Cancer Institute (Frederick, MD). Female
B6.129S7-Il1r1tm1Imx/J mice (IL-1R knockout (KO)) were
purchased from Jackson Laboratories (Bar Harbor, ME,
USA). These mice were housed in the Animal Care Fa-
cility of Northwestern University. Experimental proce-
dures that were approved by the Animal Care and Use
Committee (ACUC) of Northwestern University in ac-
cordance with NIH animal care guidelines were used in
this study.
Synthetic peptides and antibodies
All peptides used were purchased from GeneMed (Gen-
eMed Synthesis Inc, CA, USA) and used as described
previously [20]. All antibodies used were purchased from
BD Pharmingen (San Diego, CA, USA).
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Virus
The BeAn strain of TMEV was generated, propagated,
and titered in BHK-21 cells grown in Dulbecco’s modi-
fied Eagle medium supplemented with 7.5% donor calf
serum as previously described [21]. Viral titer was deter-
mined by plaque assays on BHK cell monolayers.
Viral infection of mice and assessment of clinical signs
For intracerebral (i.c.) infection, 30 μl virus solution,
containing 1×106 pfu, was injected into the right cere-
bral hemisphere of 6 to 8 week-old mice (n = 10 per
group) anesthetized with isoflurane. Clinical symptoms
of disease were assessed weekly on the following grading
scale: grade 0 = no clinical signs; grade 1 =mild waddling
gait; grade 2 = severe waddling gait; grade 3 =moderate
hind limb paralysis; grade 4 = severe hind limb paralysis
and loss of righting reflex.
Reverse-transcriptase PCR and real-time PCR
Total cellular RNA from the brain and spinal cord of
infected SJL/J mice was isolated using TrizolW Reagent
(Invitrogen, CA, USA). First-strand cDNA was synthe-
sized from 1 μg total RNA utilizing SuperScriptW III First-
Strand Synthesis Supermix or M-MLV (Invitrogen). The
cDNAs were amplified with specific primer sets using the
SYBR Green Supermix (Bio-Rad) on an iCycler (Bio-Rad).
Primers for control GAPDH and cytokine genes were pur-
chased from Integrated DNA Technologies. GAPDH:
forward primer, AACTTTGGCATTGTGGAAGG and re-








GATCC and AGACACCTTGGTCTTGGAGCTT; IFN-γ:
ACTGGCAAAAGGATGGTGAC and TGA GCTCATT
GAATGCTTGG; IL-17A: CTCCAGAAGGCCCTCA
GACTAC and AGCTTTCCCTCCGCATTGACACAG;
IL-6: AGTTGCCTTCTTGGGACTGA and TCCACGA
TTTCCCAGAGAAC; TNF-α: GGTCACTGTCCCAGCA
TCTTand CTGTGAAGGGAATGGGTGTT.
Isolation of CNS-infiltrating mononuclear cells (MNCs)
Mice were perfused with sterile Hank’s balanced salt so-
lution (HBSS), and excised brains and spinal cords of 3
mice per group were homogenized. CNS-infiltrating
MNCs were then enriched in the one third bottom frac-
tion of a continuous Percoll (Pharmacia, Piscataway, NJ,
USA) gradient after centrifugation for 30 minutes at
27,000 g as described previously [22].
Flow cytometry
CNS-infiltrating lymphocytes were isolated, and Fc
receptors were blocked using 100 μL of 2.4G2 hybridoma
(ATCC) supernatant by incubating at 4°C for 30 minutes.
Cells were stained with anti-CD8 (clone 53–6.7), anti-
CD4 (clone GK1.5), anti-CD11b (clone M1/70), anti-
NK1.1 (clone PK136), anti-GR-1 (clone RB6-8C5) and
anti-CD45 (clone 30-F11) antibodies. All antibodies used
for flow cytometry were purchased from BD Pharmingen
(San Diego, CA). Cells were analyzed using a Becton Dick-
inson LSRII flow cytometer.
Intracellular staining of cytokine production
Freshly isolated CNS-infiltrating MNCs from three mice
per group were cultured in 96-well round-bottom plates
in the presence of the relevant or control peptide as pre-
viously described [23]. Allophycocyanin-conjugated anti-
CD8 (clone Ly2) or anti-CD4 (clone L3T4) antibodies
and a PE-labeled rat monoclonal anti-IFN-γ (XMG1.2)
antibody were used for intracellular cytokine staining.
Cells were analyzed on a Becton Dickinson FACS Cali-
bur or LSRII cytometer. Live cells were gated based on
light scattering properties.
T cell proliferation assay
Splenocytes from TMEV-infected mice, CD4+ T cells
from spleens of OTII mice stimulated with specific epi-
tope peptide, or in vitro TMEV-infected peritoneal
macrophages in the presence of 2 μM ovalbumin
(OVA)-specific peptides or 100 μg OVA protein were
used. Cultures were incubated in 96-well flat-bottomed
microtiter plates for 72 h and then pulsed with 1.0 μCi
[3H]TdR and harvested 18 h later. [3H]TdR uptake by
the cells was determined in triplicate using a scintillation
counter and expressed as net counts per minute (Δcpm)
± standard error of the mean (SEM) after subtraction of
the background count of cultures with PBS instead of
stimulators.
Histopathological analyses
At 70 days post-infection, mice were anesthetized and
perfused via intracardiac puncture with 50 mL of PBS.
Brain and spinal cords from IL-1R KO and B6 control
mice were dissected and fixed in 4% formalin in PBS for
24 h. Anterior cortex (bregma: 3.0 to 2.0 mm), subven-
tricular zone (bregma: 1.7 to 0.48), hippocampus
(bregma: -1.0 to −2.5 mm), and cerebellum (bregma:
-5.6 to −7.0 mm) were investigated. In addition, cervical,
thoracic, and lumbar regions of the spinal cord were also
examined. The tissues were embedded in paraffin for
sectioning and staining. Paraffin-processed brains and
spinal cords were sectioned at 6 μm. Adjacent sets of
three sections from each animal were deparaffinized,
rehydrated, and evaluated by H & E staining for
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inflammatory infiltrates, Luxol Fast Blue (LFB) staining
for axonal demyelination, and Bielschowsky silver stain-
ing for axon loss. Slides were examined using a Leica
DMR light microscope, and images were captured using
an AxioCam MRc camera and AxioVision imaging soft-
ware. The inflammatory infiltrates were evaluated by the
presence or absence of the monocytes/lymphocytes
based on the H & E staining and immunofluorescent
staining of CD45+ cells. Histologic white matter demye-
lination was graded as: 1) normal myelination, 2) mild
or minor demyelination (> 50% myelin staining pre-
served), or 3) moderate to severe demyelination (< 50%
myelin staining preserved).
ELISA
Cytokine levels produced by splenocytes from TMEV-
infected mice or CD4+ T cells from spleens of OTII mice
were determined after stimulation with specific epitope
peptides (2 μM each), or in vitro TMEV-infected peri-
toneal macrophages in the presence of OVA-specific
peptide (2 μM) for 72 h, respectively. IFN-γ (OPTEIA
kit; BD Pharmingen), IL-17 (R&D Systems, Minneapolis,
MN, USA) levels were assessed. Plates were read using a
Spectra MAX 190 microplate reader (Molecular Devices,
Sunnyvale, CA, USA) at a 450 nm wavelength.
Statistical analysis
Data were presented as mean ± SD of either two to three
independent experiments or one representative of at
least three separate experiments. The significance of dif-
ferences in the mean values was determined by Student’s
t-test. Clinical scores were analyzed by Mann–Whitney
U-test. P values < 0.05 were considered statistically
significant.
Results
Administration of IL-1β promotes a Th17 response to
TMEV to exacerbate the pathogenicity of demyelinating
disease
We have previously demonstrated that administration of
LPS or IL-1β causes resistant C57BL/6 mice to develop
demyelinating disease [18]. It has recently been shown
that LPS treatment promotes this pathogenesis by ele-
vating the induction of the pathogenic Th17 response
[17]. However, it is unknown how IL-1β promotes this
pathogenesis. To understand the mechanism, we com-
pared the levels of Th1 and Th17 in the CNS of B6 mice
treated with either LPS or IL-1β, along with control
mice treated with PBS, following infection with TMEV at
8 days post-infection (Figure 1). The results clearly indi-
cated that the levels of IL-17A-producing Th17 cells in
mice treated with either LPS or IL-1β were significantly
elevated compared to PBS-treated control mice
(Figure 1A and B). In contrast, the levels of IFN-γ-
producing Th1 cells were not different. It is interesting
to note that IL-1β-treated mice exceeded the Th17 level
of LPS-treated mice. However, the levels of IL-17-
producing CD8+ T cells were minimal (not shown), and
Figure 1 Effects of IL-1β administration on Th17 and Th1 responses in TMEV-infected B6 mice. (A) Levels of IFN-γ- and IL-17-producing
CD4+ T cells in B6 mice intraperitoneally treated with PBS, lipopolysaccharide (LPS), or IL-1β during the early stage (−1 and 3 days post-infection
(dpi)) of Theiler’s murine encephalitis virus (TMEV) infection (three mice per group) were analyzed using flow cytometry of the pooled central
nervous system (CNS) cells at 8 dpi after stimulation with either PBS or anti-CD3/CD28 antibodies. (B) The overall numbers of IL-17-producing
cells in the CNS of the above treated B6 mice (three mice per group) were shown. (C) Levels of IFN-γ-producing CD8+ T cells in the CNS of these
groups of mice were also similarly analyzed. ***P< 0.001.
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the levels of IFN-γ-producing CD8+ T cells were also
similar among the groups (Figure 1C). These results
strongly suggest that IL-1β can promote the pathogen-
esis of TMEV-induced demyelinating disease by enhan-
cing the induction of pathogenic Th17 cells rather than
altering the Th1 response.
IL-1R KO mice are susceptible to TMEV-induced
demyelinating disease and display high cellular
infiltration to the CNS
Although administration of IL-1β promotes the patho-
genesis of TMEV-induced demyelinating disease, the IL-
1β produced via NLRP3 proteosome activation upon
viral infection is considered to be a protective mechan-
ism against microbial infections by promoting the apop-
tosis of infected cells [24]. To further investigate the
potential role of IL-1β-mediated signaling in the devel-
opment of TMEV-induced demyelinating disease, we
compared the development of TMEV-induced demyelin-
ating disease in IL-1R KO mice with a B6 background
and control B6 mice (Figure 2A). Every IL-1R KO mouse
developed demyelinating disease while none of the con-
trol B6 mice showed clinical signs at 35 days post-
infection (dpi). The results clearly indicated that B6 mice
with the deficiency in IL-1 signaling became susceptible
to the TMEV-induced disease. This is somewhat unex-
pected because our previous study indicated that admin-
istration of IL-1β to B6 mice renders the mice
susceptible to the disease, suggesting a pathogenic role
for IL-1β in disease development.
To correlate the disease susceptibility of IL-1R KO
mice with viral persistence in the CNS, the relative viral
message levels in the CNS of wild type (WT) B6 and IL-
1R KO mice were compared at days 8, 21 and 70 post-
infection with TMEV (Figure 2B). The results showed
that the level of viral load in the spinal cord, but not in
the brain, is consistently higher in IL-1R KO mice com-
pared to control B6 mice. These results strongly suggest
that IL-1 signaling plays an important role in controlling
viral persistence in the spinal cord during the course of
TMEV infection. However, it was previously shown that
the viral load level alone is not sufficient for the patho-
genesis of TMEV-induced demyelinating disease [25].
Thus, we further assessed the levels of cellular infiltra-
tion to the CNS of these mice during the early stages (3
and 8 dpi) of viral infection (Figure 2C). The results
indicated that infiltration into the CNS of granulocytes,
NK cells, macrophages and CD8+ T cells but not CD4+
T cells was elevated, particularly at the early stage of
viral infection. These results collectively suggest that
high viral loads and cellular infiltration into the CNS in
resistant B6 mice in the absence of IL-1 signaling leads
to the elevated development of TMEV-induced demye-
linating disease.
IL-1R KO mice show widely spread mild demyelinating
lesions accompanied by patchy axon damage
At 70 days post-infection, the histopathology of TMEV-
infected IL-1R KO and B6 mice was compared to correl-
ate the disease development with the histopathology of
the CNS (Figure 3). Series of histopathological examina-
tions of the spinal cords from both KO and WT mice
were conducted after H & E, LFB, and Bielschowsky sil-
ver staining. The H & E staining was used for evaluating
the evidence of active inflammation and lymphocyte in-
filtration. LFB specifically stains axonal myelin sheath,
and this was used to evaluate the axonal demyelination.
Bielschowsky silver staining stains axons dark brown
and was used to evaluate axonal integrity. Lymphocyte
infiltration, minor demyelination and axon loss were
detected in the CNS, including the brain and spinal
cord, in IL-1R KO mice but not in WT B6 mice. Com-
pared to control B6 mice (Figure 3A a-b), IL-1R KO
mice (Figure 3A c-d) showed more lymphocyte infiltra-
tion in the white matter of the lumbar spinal cord when
examined by H & E staining. LFB staining of the adja-
cent sections showed irregular vacuoles and demyelin-
ation in the white matter of the spinal cord in IL-1R KO
mice (Figure 3A g-h) and in brain regions including the
cerebellum and medulla (not shown). In contrast, myelin
that appeared normal and little histopathological change
were observed in the control B6 mice (Figure 3A e-f ).
Bielschowsky silver staining of the adjacent sections also
showed irregular vacuolation and mild axon loss in the
demyelinated regions of the spinal cord from IL-1R KO
mice (Figure 3A k-l) but not in the sections from the
WT control mice (Figure 3A i-j). To further compare
the cellular infiltration levels in the CNS of these mice,
we examined the levels of CD45+ cells in the CNS which
largely represents infiltrating cells (Figure 3B). Our
results clearly displayed that the level of CD45+ cells
(Figure 3B d), many of which overlap with H & E stain-
ing Figure 3B c), was higher in the CNS of IL-1R KO
mice compared to that of the control B6 mice
(Figure 3B a-b).
Cytokine gene expression is transentily higher in the CNS
of IL-1R KO mice during early viral infection
To understand the susceptibility to TMEV-induced de-
myelinating disease in IL-1R KO mice, we analyzed vari-
ous cytokine message levels expressed in the CNS of
virus-infected control and IL-1R KO mice during the
early stages (3, 5, and 8 dpi) of viral infection using real-
time PCR (Figure 4). The levels of IFN-α and IFN-β
gene expression in IL-1R KO mice were significantly
higher than those in B6 mice at 3 dpi, although the
levels became similar at 5 and 8 dpi. The expression
levels of CXCL-10 that were associated with T cell infil-
tration and IL-10 that was associated with viral
Kim et al. Journal of Neuroinflammation 2012, 9:217 Page 5 of 13
http://www.jneuroinflammation.com/content/9/1/217
Figure 2 The course of TMEV-induced demyelinating disease development, viral persistence levels and CNS-infiltrating mononuclear
cells in TMEV-infected in B6 and IL-1R KO mice. (A) Frequency and severity of demyelinating disease in B6 (n = 10) and IL-1R knockout (KO)
(n = 10) mice were monitored for 70 days after Theiler’s murine encephalitis virus (TMEV) infection. (B) Viral persistence levels in the pooled brains
(BR) and spinal cords (SC) of infected mice (three mice per group) at 8, 21 and 70 days post-infection (dpi) were determined by quantitative PCR.
Data are expressed by fold induction after normalization to the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA levels. The values
are expressed as the means ± SD of triplicate experiments. Statistically significant differences are indicated with asterisks;*P< 0.05, **P< 0.01,
***P< 0.001. (C) Levels of T cells (CD4+ and CD8+), macrophages (CD11b+CD45high), microglia (CD11b+CD45int), NK cells (NK1.1+CD45+) and
granulocytes (Ly6G/6C+CD45+) were assessed using flow cytometry in central nervous system (CNS)-infiltrating mononuclear cells from TMEV-
infected C57BL/6 and IL-1R KO mice at 3 and 8 dpi. Numbers in FACS plots represent percentages in the CNS. Data are representative of three
experiments using three mice per group.
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persistence were higher at 5 dpi, and this trend was main-
tained at 8 dpi. However, the expression level of IL-6 in
IL-1R KO mice was transiently lower at 5 dpi, while no
differences in TNF-α expression were noted. Similarly, the
production of a pathogenic T cell cytokine, IL-17 was
largely unchanged. However, viral RNA and the produc-
tion of IFN-γ were transiently higher at 3 and 8 dpi. These
results suggest that the lack of IL-1 signaling differentially
affects viral replication and the expression of various in-
nate and immune cytokines depending on the stage of
TMEV infection.
Anti-viral CD4+ T cell responses in the CNS, of virus-
infected IL-1R KO mice are lower during the early stage
of infection
To compare CD4+ T cell responses specific to viral
determinants in the CNS of IL-1R KO and WT mice,
infiltration levels of CD4+ T cells specific to the predom-
inant CD4+ T cell epitopes were assessed (Figure 5A and
B). The levels of IFN-γ-producing CD4+ T cells in re-
sponse to pan-T cell stimulation (either PMA plus iono-
mycin or anti-CD3 and anti-CD28 antibodies) were
similar between IL-1R KO and control WT B6 mice.
However, such CD4+ T cell responses to viral epitopes
were proportionally lower in the CNS of virus-infected
IL-1R KO mice compared to B6 mice, although the
overall levels in the CNS were similar. This discrepancy
may be due to the high levels of CXCL-10 expression
(Figure 4), which promotes infiltration of T cells, in the
CNS of IL-1R KO mice. The levels of IL-17-producing
CD4+ T cells in either TMEV-infected IL-1R KO or B6
mice were undetectable. To further determine whether
the pattern of CD4+ T cell responses is unique in the
CNS of virus-infected mice, we also assessed the T cell
Figure 3 Histopathology of the spinal cord in IL-1R KO and wild-type mice. (A) H & E staining of the spinal cord showed infiltration of
inflammatory cells in knockout (KO) mice (c, d) and little infiltration in wild-type (WT) mice (a, b). Luxol Fast Blue (LFB) staining of adjacent
sections showed irregular vacuolation and minor demyelination in the white matter of KO mice (g, h) but no loss of myelin in WT mice (e, f).
Bielschowsky silver staining of the same area shows the presence of irregular vacuolation and minor axonal loss in KO mice (k, l) but not in WT
mice (i, j). Magnification, ×10 and ×40. Black arrows indicate regions of lymphocyte infiltrates, demyelination, or axon loss; thin black squares
indicate the areas from the lumbar spinal cord region, which are shown in high magnification (b, f, and j for B6 mice and d, h, and l for IL-1R KO
mice). (B) H & E staining of spinal cords of control (a) and IL-1R KO mice (c) are shown. The adjacent sections (b and d, respectively) were stained
with anti-CD45 antibody (red) for infiltrating cells and counterstained with 4',6-diamidino-2-phenylindole (DAPI) (blue) for nuclei.
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responses in the periphery of TMEV-infected IL-1R KO
and control B6 mice at 8 and 21 dpi (Figure 5C). Again,
the levels of T cell proliferation and the production of
key T cell cytokines (IFN-γ and IL-17) against viral epi-
topes (for both CD4+ and CD8+ T cells) were not drasti-
caly different between the splenic T cells from IL-1R KO
and control B6 mice. Despite the similar low levels of
IL-17 production in response to viral epitopes, the
IL-17 level was significantly lower in IL-1R KO mice
compared to WT B6 mice after robust stimulation
with anti-CD3/CD28 antibodies. These results are
consistent with the role of IL-1 signaling in promot-
ing IL-17 production [26,27].
Levels of TMEV-specific CD8+ T cell responses in the CNS
are comparable between IL-1R KO and WT B6 mice
To further determine whether the susceptibility of IL-1R
KO mice to TMEV-induced demyelinating disease is
associated with a compromised anti-viral CD8+ T cell re-
sponse, we also analyzed the T cell responses in the CNS
of TMEV-infected IL-1R KO and control B6 mice
Figure 4 Expression level of cytokine genes in the CNS of
TMEV infected B6 and IL-1R knockout (KO) mice at 3, 5 and 8
days post-infection (dpi). The relative expression levels of the
indicated mRNAs in the central nervous system (CNS) of Theiler’s
murine encephalitis virus (TMEV)-infected C57BL/6 and IL-1R KO
mice at 3, 5 and 8 dpi were assessed by real-time PCR. Data are
expressed by fold induction after normalization to the
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA levels.
The values are expressed as the means ± SD of triplicates. Statistically
significant differences are indicated with asterisks; *P< 0.05,
**P< 0.01, ***P < 0.001).
Figure 5 Virus-specific CD4+ T cell responses in the CNS and
the periphery of TMEV-infected B6 and IL-1R knockout (KO)
mice. (A) Levels of Th1 and Th17 cells in the central nervous system
(CNS) of virus-infected B6 and IL-1R KO mice were assessed using
flow cytometry at 8 days post-infection (dpi) after stimulation with
PBS, PMA/ionomycin, anti-CD3/CD28 antibodies, or viral epitope
peptides (Pep: mixture of 2 μM VP2203-220 and 2 μM VP425-38). The
flow cytometric plots show gated CD4+ T cells. (B) The numbers of
CNS-infiltrating IFN-γ-producing CD4+ T cells reactive to either viral
epitope peptides (CD4: equal mixture of VP2203-220 and VP425-38) or
anti-CD3/CD28 antibodies in virus-infected B6 and IL-1R KO mice
(three mice each) at 8 and 21 dpi. A representative result from two
to three similar experiments is shown here. (C) Levels of proliferation
and cytokine production by splenic T cells in response to viral
epitopes by CD4+ T cells (CD4 Mix: equal mixture of VP2203-220 and
VP425-38), CD8
+ T cells (VP2-121–130), or both CD4
+ and CD8+ T cells
(anti-CD3/CD28 antibodies) were assessed at 8 and 21 dpi. Values
are expressed as the mean of triplicate samples (mean ± SD) from a
representative of three experiments. *P< 0.05, **P< 0.01, ***P< 0.001.
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(Figure 6). Virus-specific CD8+ T cells reactive to the
predominant epitope (VP2121-130), determined using the
VP2121-H-2D
b tetramer, indicated that the proportions
of virus-specific CD8+ T cells in the CNS of virus-
infected WT B6 and IL-1R KO mice are similar
(Figure 6A). To further determine whether the functions
of the virus-reactive CD8+ T cells are different, we
assessed the abilities of the cells to produce IFN-γ in re-
sponse to specific and non-specific stimulations
(Figure 6B). The results clearly indicated that their abil-
ity to produce IFN-γ is also similar in both proportion
(Figure 6B) and number in the CNS of TMEV-infected
B6 and IL-1R KO mice (Figure 6C). These results
strongly suggest that there are no significant differences
in the CD8+ T cell responses to the viral determinants,
unlike those of CD4+ T cell responses, in the CNS of
virus-infected WT B6 and IL-1R KO mice.
Cytokine production by Th cells stimulated with
macrophages from IL-1R KO mice is reduced
To compare the function of CD4+ T cells stimulated by
macrophages from B6 and IL-1R KO mice, T cells from
naïve OT-II mice, which carry T cell receptor (TCR)
transgenes specific for OVA323-339, were stimulated with
peritoneal macrophages infected in vitro for 24 h with
TMEV (10 MOI) in the presence of OVA323-339 peptide
(Figure 7A) or OVA protein (not shown). Viral infection
did not significantly alter the levels of T cell stimulation
by these macrophages. However, proliferation of CD4+ T
cells in response to the cognate peptide or protein was
higher when stimulated with IL-1R KO macrophages
compared to the proliferation stimulated with B6 macro-
phages. In contrast, IFN-γ and IL-17 production by the
T cells stimulated with IL-1R KO macrophages were sig-
nificantly lower than the production stimulated with
control B6 macrophages. These results indicated that
antigen-presenting cells display altered T cell stimulating
function in the absence of IL-1R-mediated signaling.
To further understand the potential mechanisms
underlying the altered T cell stimulation by IL-1R KO
macrophages, we examined the potential contribution of
IL-1 signaling to the induction of cytokines in TMEV-
infected macrophages (Figure 7B). After TMEV infection
in vitro for 24 h, levels of viral RNA as well as IFN-α
and IFN-β messages were similar between macrophages
from WT B6 and IL-1R KO mice. However, the expres-
sion of the IL-6 message was extremely compromised in
IL-1R KO macrophages compared to B6 macrophages.
In contrast, the expression level of TNF-α message was
more highly upregulated in IL-1R KO macrophages after
TMEV infection. Interestingly however, the expression
of TGF-β in uninfected IL-1R KO macrophages was
higher than the expression in B6 macrophages but
reduced to a similar level after viral infection. These
results suggest that the cytokine production profile of
macrophages and perhaps other antigen-presenting cells
is altered in the absence of IL-1 signaling, which may
affect the initial development and/or function of T cells
following viral infection.
To further understand the underlying mechanisms
associated with altered CD4+ T cell development in the
absence of IL-1 signaling, the levels of co-stimulatory
molecules and key inhibitory molecules were studied in
a representative macrophage antigen-presenting cell
(APC) population (Figure 7C). The levels of CD80,
CD86 and CD40 in B6 and IL-1R1 KO mice were not
significantly different (not shown). However, PDL-1 and
Tim-3 were significantly elevated in the absence of IL-1
signaling. These molecules are known to negatively
affect the function of T cells [28] and/or promote in-
flammatory responses through its expression by innate
immune cells, such as microglia [29]. It was interesting
to note that the expression of PDL-1 was upregulated
upon viral infection in B6 macrophages, whereas the ex-
pression in IL-1R-deficient macrophages was constitu-
tively upregulated even in the absence of viral infection.
In contrast, the expression of Tim-3 was constitutively
upregulated in IL-1R-deficient macrophages to the level
Figure 6 Levels of virus-specific CD8+ T cell responses in the
CNS of virus-infected B6 and IL-1R KO mice. (A) Levels of
H-2Db-VP2-121–130-tetramer reactive CD8
+ T cells in the central
nervous system (CNS) of B6 and IL-1R knockout (KO) mice at 8 days
post-infection (dpi). (B) Proportions of CNS-infiltrating CD8+ T cells
reactive to viral epitopes, anti-CD3/CD28 antibodies and PMA/
ionomycin were assessed using flow cytometry following
intracellular cytokine staining at 8 dpi. (C) The overall numbers of
virus-specific and anti-CD3/CD28 reactive CD8+ T cells in the CNS of
virus-infected B6 and IL-1R KO mice are shown at 8 and 21 dpi. A
representative result from two to three similar experiments is shown
here.
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(approximately 5%) of upregulation seen after viral infec-
tion in B6 macrophages, but it was further upregulated
in IL-1R KO macrophages after TMEV infection. These
results strongly suggest that these increases in the in-
hibitory molecules may participate in the altered T cell
development and/or function.
Figure 7 Cytokine reduction of CD4+ T cells with stimulation of IL-1R KO macrophages. (A) Isolated CD4+ T cells (1 × 105) from the spleen
of OT-II mice were cultured with in vitro 10 MOI Theiler’s murine encephalitis virus (TMEV)-infected peritoneal macrophages (1 × 104) from either
C57BL/6 or IL-1R knockout (KO) mice for 3 days in the presence of 2 μM OVA epitope peptides. T cell proliferative responses were analyzed using
[3H]TdR uptake, and cytokine production (IFN-γ and IL-17) of the cultures were analyzed using specific ELISAs. (B) Isolated CD4+ T cells (1 × 105)
from the spleen of B6 mice infected with TMEV at 8 days post-infection (dpi) were cultured with in vitro TMEV-infected (10 MOI for 24 h)
peritoneal macrophages (1 × 104) from either naïve C57BL/6 or IL-1R KO mice for 3 days in the presence of viral epitope peptides. Message levels
of the indicated genes were then analyzed by real-time PCR. The glyceraldehyde-3-phosphate dehydrogenase (GAPDH) level was used as an
internal control. The values are expressed as the means ± SD of triplicates. Statistically significant differences are indicated with asterisks; *P< 0.05,
**P< 0.01, ***P< 0.001. Data shown are the representation of three independent experiments. (C) Peritoneal CD11b+ cells from naïve B6 and IL-1R
KO mice infected with TMEV in vitro for 24 h were analyzed for the expression of PDL-1 and TIM-3 T cell inhibitory molecules. A representative
flow cytometry plot of three similar results is shown here.
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Discussion
TMEV-infection in susceptible strains of mice induces
chronic demyelinating disease that is primarily mediated
by CD4+ T cells [17,30,31]. However, epitope-specific
CD4+ T cells can be protective or pathogenic depending
on when activated T cells are available in conjunction
with viral infection [23,32,33]. Interestingly, the level of
IL-1β, induced following infection with TMEV, plays an
important role in the pathogenesis of TMEV-induced
demyelinating disease [18,34]. Previously, it has been
shown that administration of IL-1 to mice exacerbates
the development of experimental autoimmune enceph-
alomyelitis (EAE), the pathogenic immune mechanisms
of which are similar to those of TMEV-induced demye-
linating disease [35-37]. In addition, IL-1 appears to dir-
ectly activate astrocytes and microglia to exacerbate
neurodegeneration in non-immune-mediated diseases
[38]. Because IL-1β is induced via the innate immunity
mediated by various TLRs and because the downstream
IL-1 signals mediated via IL-1R also play an important
role in the host defense [1,4], we have investigated the
role of IL-1β signals in the development of TMEV-
induced demyelinating disease by assessing the effects of
IL-1β administration and using IL-1R-deficient mice.
We have previously demonstrated that administration
of IL-1β into resistant B6 mice renders the resistant mice
susceptible to TMEV-induced demyelinating disease
[18]. The administration of IL-1β dramatically increased
the level of IL-17 production in the CNS of the resistant
mice, which do not produce a high level of Th17 cells fol-
lowing TMEV infection (Figure 1). This result is consist-
ent with recent reports that IL-1β strongly promotes the
development of IL-17-producing Th17 cells either dir-
ectly or via the production of IL-6 [19,39]. The presence
of high levels of IL-17A in mice infected with TMEV
exerts a strong pathogenic role by inhibiting the apop-
tosis of virus-infected cells, blocking cytolytic CD8+ T
cell function, and elevating cellular infiltration to the
CNS [17]. Recently, it was also shown that the presence
of FoxP3+ Treg cells that preferentially expand due to
stimulation by IL-1β [40] is not beneficial for the devel-
opment of TMEV-induced demyelinating disease; hence,
these regulatory cells inhibit the protective anti-viral im-
mune responses [41]. Therefore, administration of IL-1β,
resulting in a higher level of IL-1β, appears to promote
the pathogenesis of TMEV-induced demyelinating dis-
ease in resistant B6 mice by elevating pathogenic Th17
and Treg responses to TMEV antigens. In addition, it is
known that IL-1 directly activates astrocytes and micro-
glia in the CNS [42], which are associated with the
pathogenesis of TMEV-induced demyelinating disease
[13,43]. Furthermore, IL-1 mediates the loss of astroglial
glutamate transport and drives motor neuron injury in
the spinal cord during viral encephalomyelitis [44]. The
expression of IL-1R1 is upregulated in glial cells follow-
ing TMEV infection [45], and thus the elevated receptor
expression is likely to exert the detrimental effects seen
as a result of IL-1 signaling on neurodegeneration and/or
pathogenic immune responses.
In the absence of IL-1R1-mediated signals, resulting
from engagements with the predominant cytokine IL-1β
and weak cytokine IL-1α, strongly resistant B6 mice be-
come susceptible to the development of TMEV-induced
disease (Figure 2). Viral loads in the spinal cord are
higher in the absence of IL-1R signals, suggesting that
the presence of IL-1 signaling plays an important role in
controlling viral persistence during the course of TMEV
infection. The high viral loads also accompanied higher
cellular infiltration into the CNS. Histopathological
examinations of the virus-infected IL-1R-deficient B6
mice confirmed the elevated lymphocyte infiltration, de-
myelination and axonal losses in the CNS compared to
control B6 mice (Figure 3). These results are consistent
with previous reports indicating that either IL-1β- or
IL-1RI-deficient mice are susceptible to various infec-
tions [1,7,8,46]. These results collectively suggest that
either an abnormally high level of IL-1β or the ab-
sence of IL-1-mediated signals lead to high viral loads
and cellular infiltration to the CNS, resulting in the ele-
vated development of TMEV-induced demyelinating dis-
ease. Therefore, a fine balance of IL-1β-mediated signaling
appears to be important for protection from viral infec-
tions. It is also interesting to note that this viral model for
MS is markedly different from the EAE model, which is
not associated with microbial infections, in that a defi-
ciency of IL-1R1 significantly reduces the development of
demyelinating disease [37].
Despite many previous studies on the role of IL-1β
signaling in viral infections, the underlying mechanisms
of the signals involved in the protection from infection
remain unclear. Previously, it has shown that IL-1-
mediated signals augment T cell responses by increasing
cellular infiltration, as well as upregulating cytokine
production and co-stimulatory molecule expression in
APCs [5,47,48]. However, our results showed that the
cellular infiltration is elevated in IL-1R1 KO mice dur-
ing the early stages of viral infection (Figure 2), al-
though the anti-viral CD4+ T cell responses in the CNS
of virus-infected IL-1R KO mice are lower without
compromising either peripheral CD4+ T cell responses
(Figure 5) or CNS CD8+ T cell responses (Figure 6).
These results suggest that the APCs associated with
CD4+ T cell responses in the CNS are primarily affected
by the absence of IL-1-mediated signaling. Our previous
studies strongly suggested that primarily the microglia
and, to a certain extent, astrocytes, harbor viral loads
and play important roles in the stimulation of the level
and type of the CD4+ T cell response [43]. In addition,
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it is known that IL-1 signaling affects the function of
these cell types [42]. Therefore, it is most likely that
these cells play an important role in the development
of anti-viral CD4+ T cell responses in the CNS during
the early stage of viral infection. Because the cytokine
production profile of APCs is altered in the absence of
IL-1 signaling, perhaps due to the elevated expression
of inhibitory molecules (Figure 7), similar mechanisms
by CNS APCs may negatively affect the initial develop-
ment and/or function of anti-viral T cells following viral
infection. Regarding the underlying mechanisms, it is
currently unclear how the deficiency in IL-1 signals
enhances the expression of inhibitory molecules in
APCs. However, we have observed that APCs from sus-
ceptible SJL mice expressed significantly higher levels of
these molecules upon viral infection either in vitro or
in vivo compared to cells from resistant B6 mice (data
not shown), suggesting that the viral load may lead to
the elevated expression. Therefore, it is most likely that
the absence of IL-1 signals permits the initial elevation
of viral load (Figure 4), and the higher viral load, in
turn, leads to an eventual compromise in the efficiency
of anti-viral T cell responses and functions. In contrast,
the presence of excessive IL-1 signals preferentially trig-
gers T cell responses that are unfavorable for the pro-
tection of the hosts from chronic viral persistence and
the pathogenesis of demyelinating disease, as previously
seen [17,19].
Conclusions
IL-1 signaling plays a protective role against viral infec-
tions. However, we have previously demonstrated that
administration of IL-1 promotes the pathogenesis of
TMEV-induced demyelinating disease, similar to the
autoimmune disease model (EAE) for MS. The IL-1-
mediated pathogenesis of TMEV-induced demyelinating
disease appears to reflect an elevated Th17 response in
the presence of IL-1. However, IL-1R-deficient B6 mice
also induced TMEV-induced demyelinating disease ac-
companied by high viral persistence and upregulated ex-
pression of T cell inhibitory molecules such as PDL-1
and Tim-3. These results suggest that the presence of
high IL-1 level promotes the pathogenesis by elevating
Th17 responses, whereas the absence of IL-1 signals per-
mits viral persistence in the CNS due to insufficient T
cell activation. Therefore, the balance of IL-1 signaling
appears to be critical for the determination of protection
vs. pathogenesis in the development of a virus-induced
demyelinating disease.
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